0
We're unable to sign you in at this time. Please try again in a few minutes.
Retry
We were able to sign you in, but your subscription(s) could not be found. Please try again in a few minutes.
Retry
There may be a problem with your account. Please contact the AMA Service Center to resolve this issue.
Contact the AMA Service Center:
Telephone: 1 (800) 262-2350 or 1 (312) 670-7827  *   Email: subscriptions@jamanetwork.com
Error Message ......

Journal Articles

in Drug Therapy
 201-220 of 522 Articles
Invited Commentary | 
Karen J. Wernli, PhD; John M. Inadomi, MD
JAMA Intern Med. 2013;173(7):556-558. doi:10.1001/jamainternmed.2013.4071.

Evidence to Practice | 
Lisa Bero, PhD
JAMA Intern Med. 2013;173(7):580-581. doi:10.1001/jamainternmed.2013.4190.

Original Investigation |  FREE
Marcello Maggio, MD, PhD; Andrea Corsonello, MD; Gian Paolo Ceda, MD; et al.
JAMA Intern Med. 2013;173(7):518-523. doi:10.1001/jamainternmed.2013.2851.
Includes: CME

Original Investigation |  FREE
Jason D. Wright, MD; Alfred I. Neugut, MD, PhD; Cande V. Ananth, PhD; et al.
JAMA Intern Med. 2013;173(7):559-568. doi:10.1001/jamainternmed.2013.2921.

Review Article |  FREE
Timothy J. Wilt, MD, MPH; Roderick MacDonald, MS; Jeannine Ouellette; et al.
JAMA Intern Med. 2013;173(7):496-505. doi:10.1001/jamainternmed.2013.3733.
Includes: Supplemental Content

Research Letters |  FREE
Yuting Zhang, PhD; Shang-Hua Wu, MS; A. Mark Fendrick, MD; et al.
JAMA Intern Med. 2013;173(6):468-470. doi:10.1001/jamainternmed.2013.2509.

Original Investigation |  FREE
Omid Sadr-Azodi, MD, PhD; Fredrik Mattsson, BSc; Tomas Sjöberg Bexlius, MD, PhD; et al.
JAMA Intern Med. 2013;173(6):444-449. doi:10.1001/jamainternmed.2013.2737.

Original Investigation |  FREE
Elissa R. Weitzman, ScD, MSc; Skyler Kelemen, BA; Maryanne Quinn, MD, MPH; et al.
JAMA Intern Med. 2013;173(5):345-351. doi:10.1001/jamainternmed.2013.2512.

Original Investigation |  FREE
Nicole Yvonne Nguyen, PharmD; Lisa Bero, PhD
JAMA Intern Med. 2013;173(5):338-343. doi:10.1001/jamainternmed.2013.2522.

Invited Commentary | 
Nirav Shah, MD, MPH
JAMA Intern Med. 2013;173(5):344. doi:10.1001/jamainternmed.2013.4184.

Research Letters |  FREE
Alan J. Forster, MD, MSc; Claudine Auger, PhD; for the ISTOP ADE Investigators
JAMA Intern Med. 2013;173(5):382-384. doi:10.1001/jamainternmed.2013.2002.

Invited Commentary | 
Michael A. Steinman, MD
JAMA Intern Med. 2013;173(5):384-385. doi:10.1001/jamainternmed.2013.2965.

Research Letters |  FREE
Peter Doshi, PhD; Tom Jefferson, MD
JAMA Intern Med. 2013;173(5):380-382. doi:10.1001/jamainternmed.2013.3838.
Includes: Supplemental Content

Commentary | 
Robert Steinbrook, MD
JAMA Intern Med. 2013;173(5):373-374. doi:10.1001/jamainternmed.2013.3842.

Original Investigation |  FREE
Ralph Gonzales, MD, MSPH; Tammy Anderer, PhD, CRNP; Charles E. McCulloch, PhD; et al.
JAMA Intern Med. 2013;173(4):267-273. doi:10.1001/jamainternmed.2013.1589.

Original Investigation |  FREE
Gerald Liew, PhD; Paul Mitchell, PhD; Tien Yin Wong, PhD; et al.
JAMA Intern Med. 2013;173(4):258-264. doi:10.1001/jamainternmed.2013.1583.

Invited Commentary | 
Sanjay Kaul, MD; George A. Diamond, MD
JAMA Intern Med. 2013;173(4):264-266. doi:10.1001/jamainternmed.2013.2530.

Original Investigation |  FREE
Robert Gross, MD, MSCE; Scarlett L. Bellamy, ScD; Jennifer Chapman, MPH; et al.
JAMA Intern Med. 2013;173(4):300-306. doi:10.1001/jamainternmed.2013.2152.

Invited Commentary | 
David R. Bangsberg, MD, MPH; Jessica E. Haberer, MD, MS
JAMA Intern Med. 2013;173(4):306-307. doi:10.1001/jamainternmed.2013.2858.

Invited Commentary | 
Jeffrey A. Linder, MD, MPH
JAMA Intern Med. 2013;173(4):273-275. doi:10.1001/jamainternmed.2013.1984.

Sign in

Purchase Options

• Subscribe to the journal
• Rent this article ?

A free personal account provides

• Free current issues on The JAMA Network Reader
• Free quizzes on The JAMA Network Challenge
• Commenting and personalized alerts
From The JAMA Network
JAMA
Viewpoint  | 
Evaluation of Flibanserin Science and Advocacy at the FDA
Walid F. Gellad, MD, MPH; Kathryn E. Flynn, PhD; G. Caleb Alexander, MD, MS
JAMA Psychiatry
Original Investigation  | 
Evaluation of Antipsychotic Dose Reduction in Late-Life Schizophrenia A Prospective Dopamine D2/3 Receptor Occupancy Study
Ariel Graff-Guerrero, MD, PhD; Tarek K. Rajji, MD; Benoit H. Mulsant, MD, MS; et al.
JAMA Oncology
From The JAMA Network  | 
Prognostic Significance of Cutaneous Adverse Events Associated With Pembrolizumab Therapy
Jennifer A. Lo, BA; David E. Fisher, MD, PhD; Keith T. Flaherty, MD
JAMA Pediatrics
Viewpoint  | 
Global Collaboration to Develop New and Existing Drugs for Neonates
Jonathan M. Davis, MD; Mark A. Turner, MB, PhD, MRCPCH